Brief: Sk Biopharmaceuticals Signs Technology Transfer Agreement Worth $505 Mln With Ono Pharmaceutical Co
13/10/2020 07:44
Oct 13 (Reuters) -
* SK BIOPHARMACEUTICALS: SIGNS TECHNOLOGY TRANSFER AGREEMENT
WORTH
579 BILLION WON ($504.61 million) WITH ONO PHARMACEUTICAL CO
Source text for Eikon: https://bit.ly/3lFzJVR
Further company coverage: 326030.KS
($1 = 1,147.4300 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker